Classification of dementias [9] (multiple letters)

Lancet

Volumn 361, Issue 9364, 2003, Pages 1227-1228

  Whitehouse, Peter J ^a   Arai, Hiroyuki ^b   Matsui, Toshifumi ^b   Maruyama, Masahiro ^b   Okamura, Nobuyuki ^b   Sasaki, Hidetada ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; DONEPEZIL; IOFETAMINE I 123; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; BRAIN PERFUSION; CHOLINERGIC SYSTEM; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FLIGHT; GENETICS; HUMAN; HYPERTENSION; LETTER; LEWY BODY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NERVE CELL NECROSIS; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATION; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; RATING SCALE; RECALL; SCORING SYSTEM; SIMULATOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE; VASCULAR DISEASE; AGED; CEREBROSPINAL FLUID; CLASSIFICATION; FEMALE; MALE; NOTE;

AGED; COGNITION DISORDERS; FEMALE; HUMANS; MALE; TAU PROTEINS;

EID: 0037420520     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12938-8     Document Type: Letter

References (3)

1. Burns A Zaudig M Mild cognitive impairment in older people Lancet 360 2002 1963 1965
2. Maruyama M Arai H Sugita M Cerebrospinal fluid amyloid 1–42 levels in the mild cognitive impairment stage of Alzheimer's disease Exp Neurol 172 2001 433 436
3. Trojanowski JQ Clark CM Arai H Lee VM-Y Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease Alzheimer Dis Rev 1 1996 77 83